Midatech’s management is supported by a strong board of directors composed of individuals from various industries as well as academia. The breadth and depth of its members’ experience in medicine, pharmaceuticals, venture capital, strategy and general management is instrumental in providing advice and leadership to the Company.
Nearly 50 years of experience in the pharmaceutical industry, of which 20 years were spent at CEO and Board level in public and private life science companies across Europe, the US and India. Joined Shire as CEO in 1994 following a 27-year career at Wellcome plc (now GSK). Currently the Non-executive Chairman of Connexios Life Sciences Pvt Ltd, and previously the Non-executive Chairman of EUSA Pharma, Cosmos Pharmaceuticals SpA, PowderMed Ltd and Newron Pharmaceuticals SpA.
CEO and founding member of Brown Equity Partners; former founding partner of Forrest Binkley & Brown; former Senior Vice President of Bank of America Venture Capital Group; former Senior Vice President of Security Pacific Capital Corporation.
Keith J. Kendall
Co- President and Chief Operating Officer of MonoSol Rx; former Vice President and Managing Director for Hewlett Packard Financial Services; former President of AT&T Credit Corporation and NCR Credit Corporation.
Partner at Bain & Co; Bain Head of European Media, Telecommunication and Technology Practice; member of Bain & Co’s worldwide Board of Directors.
Founder and Managing Partner of Ippon Capital, and co-founder of Spacecode Holdings. Also serves on the advisory board of Socure Inc, an internet security software company.
Non-executive director of two banks; Former partner at BDO Stoy Hayward; advisor to the board of a US gaming and entertainment company.
Sijmen de Vries
CEO of Pharming N.V.; former CEO of 4-Antibody AG; former CEO of Morphochem AG; former member of the executive board of Biovertis AG; former head of Global Business Development for Novartis.
Chief Executive Officer
See Management Team